Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Down 55.9% in October

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 17,600 shares, a drop of 55.9% from the September 30th total of 39,900 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 63,100 shares, the short-interest ratio is presently 0.3 days.

Rapid Micro Biosystems Stock Performance

RPID stock traded up $0.01 during midday trading on Friday, reaching $0.92. 177,915 shares of the company traded hands, compared to its average volume of 93,532. The firm has a market capitalization of $39.43 million, a price-to-earnings ratio of -0.76 and a beta of 1.13. Rapid Micro Biosystems has a 52-week low of $0.58 and a 52-week high of $1.18. The business has a 50 day moving average of $0.86 and a 200-day moving average of $0.82.

Rapid Micro Biosystems (NASDAQ:RPID) last released its quarterly earnings results on Friday, August 2nd. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.01). The company had revenue of $6.62 million for the quarter, compared to analysts’ expectations of $6.02 million. Rapid Micro Biosystems had a negative net margin of 204.22% and a negative return on equity of 45.23%. During the same quarter in the previous year, the company posted ($0.33) EPS. Research analysts anticipate that Rapid Micro Biosystems will post -1.06 earnings per share for the current year.

Insider Activity

In related news, Director Richard S. Kollender bought 65,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was purchased at an average price of $0.77 per share, for a total transaction of $50,050.00. Following the completion of the transaction, the director now owns 96,718 shares in the company, valued at $74,472.86. The trade was a 200.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Kirk Malloy bought 50,000 shares of the stock in a transaction dated Thursday, August 8th. The stock was purchased at an average cost of $0.91 per share, for a total transaction of $45,500.00. Following the transaction, the director now owns 64,300 shares of the company’s stock, valued at $58,513. The trade was a 300.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard S. Kollender purchased 65,000 shares of Rapid Micro Biosystems stock in a transaction that occurred on Tuesday, August 6th. The stock was acquired at an average price of $0.77 per share, for a total transaction of $50,050.00. Following the transaction, the director now directly owns 96,718 shares of the company’s stock, valued at $74,472.86. The trade was a 200.00 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 175,000 shares of company stock worth $141,850 over the last quarter. Insiders own 30.40% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.